ArticleFrontiers in oncology2026

Efficacy and safety of immune checkpoint inhibitors combined with chemotherapy versus bevacizumab combined with chemotherapy in first-line treatment of driver gene-negative advanced non-squamous non-small cell lung cancer: a single-center retrospective study.

Wenqiang Mo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.